, Columnist
WebMD's Deal Prognosis: Not Great
We've been here before.
This article is for subscribers only.
Let's face it: WebMD is where your inner hypochondriac goes to neurotically self-diagnose an illness you probably don't have. (Am I just tired? Or is it lupus?) However, jumping to conclusions isn't something WebMD Health Corp.'s investors are willing to do.
The $2 billion health website said last month that it's exploring strategic alternatives, which means it's for sale. Then on Monday, Cliff Robbins's activist fund Blue Harbour Group disclosed an increased stake of nearly 9 percent, up from 4.8 percent as of December, saying that it continues to hold talks with WebMD's management and other shareholders about potentials deals, changes and whatnot.